BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 32833219)

  • 1. Is Macroscopic Portal Vein Tumor Thrombosis of HCC Really an Exclusion for Liver Transplantation?
    Aydin C; Yilmaz S
    J Gastrointest Cancer; 2020 Dec; 51(4):1137-1140. PubMed ID: 32833219
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Criteria for diagnosing benign portal vein thrombosis in the assessment of patients with cirrhosis and hepatocellular carcinoma for liver transplantation.
    Piscaglia F; Gianstefani A; Ravaioli M; Golfieri R; Cappelli A; Giampalma E; Sagrini E; Imbriaco G; Pinna AD; Bolondi L;
    Liver Transpl; 2010 May; 16(5):658-67. PubMed ID: 20440775
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of hepatocellular carcinoma in patients with portal vein tumor thrombosis: Beyond the known frontiers.
    Cerrito L; Annicchiarico BE; Iezzi R; Gasbarrini A; Pompili M; Ponziani FR
    World J Gastroenterol; 2019 Aug; 25(31):4360-4382. PubMed ID: 31496618
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Favorable survival time provided with radioembolization in hepatocellular carcinoma patients with and without portal vein thrombosis.
    Ozkan ZG; Poyanli A; Ucar A; Kuyumcu S; Akyuz F; Keskin S; Saglam S; Yilmaz E; Karaca C; Turkmen C
    Cancer Biother Radiopharm; 2015 Apr; 30(3):132-8. PubMed ID: 25760644
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Post-hepatectomy survival in advanced hepatocellular carcinoma with portal vein tumor thrombosis.
    Yamamoto Y; Ikoma H; Morimura R; Shoda K; Konishi H; Murayama Y; Komatsu S; Shiozaki A; Kuriu Y; Kubota T; Nakanishi M; Ichikawa D; Fujiwara H; Okamoto K; Sakakura C; Ochiai T; Otsuji E
    World J Gastroenterol; 2015 Jan; 21(1):246-53. PubMed ID: 25574098
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The possibility of radiotherapy as downstaging to living donor liver transplantation for hepatocellular carcinoma with portal vein tumor thrombus.
    Choi JY; Yu JI; Park HC; David Kwon CH; Kim JM; Joh JW; Choi GS; Park JB; Kim SJ; Lee SH; Cho WT; Lee KW; Na BG; Oh DK; Lee N; Cho CW; Lee S; Lee SK
    Liver Transpl; 2017 Apr; 23(4):545-551. PubMed ID: 28133933
    [No Abstract]   [Full Text] [Related]  

  • 7. [Transarterial chemoembolization (TACE) of the hepatocellular carcinoma (HCC) in patients with portal vein thrombosis--experiences].
    Herber S; Pitton M; Mönch C; Schneider J; Manzl N; Kummer I; Kanzler S; Schuchmann M; Junginger T; Düber C; Otto G
    Zentralbl Chir; 2007 Aug; 132(4):306-15. PubMed ID: 17724633
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radioembolization vs sorafenib in locally advanced hepatocellular carcinoma with portal vein tumor thrombosis: A propensity score and Bayesian analysis.
    Martelletti C; Ricotti A; Gesualdo M; Carucci P; Gaia S; Rolle E; Burlone ME; Okolicsanyi S; Mattalia A; Pirisi M; Berchialla P; Tabone M
    J Dig Dis; 2021 Aug; 22(8):496-502. PubMed ID: 34189839
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Experience With LDLT in Patients With Hepatocellular Carcinoma and Portal Vein Tumor Thrombosis Postdownstaging.
    Soin AS; Bhangui P; Kataria T; Baijal SS; Piplani T; Gautam D; Choudhary NS; Thiagarajan S; Rastogi A; Saraf N; Saigal S
    Transplantation; 2020 Nov; 104(11):2334-2345. PubMed ID: 32032291
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of hepatocellular carcinoma with portal venous tumor thrombosis: A comprehensive review.
    Han K; Kim JH; Ko GY; Gwon DI; Sung KB
    World J Gastroenterol; 2016 Jan; 22(1):407-16. PubMed ID: 26755886
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined endovascular brachytherapy, sorafenib, and transarterial chemobolization therapy for hepatocellular carcinoma patients with portal vein tumor thrombus.
    Zhang ZH; Liu QX; Zhang W; Ma JQ; Wang JH; Luo JJ; Liu LX; Yan ZP
    World J Gastroenterol; 2017 Nov; 23(43):7735-7745. PubMed ID: 29209114
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of a prognostic score to predict response to Yttrium-90 radioembolization for hepatocellular carcinoma with portal vein invasion.
    Spreafico C; Sposito C; Vaiani M; Cascella T; Bhoori S; Morosi C; Lanocita R; Romito R; Chiesa C; Maccauro M; Marchianò A; Mazzaferro V
    J Hepatol; 2018 Apr; 68(4):724-732. PubMed ID: 29331342
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transarterial chemoembolization in hepatocellular carcinoma with portal vein tumor thrombosis: a systematic review and meta-analysis.
    Silva JP; Berger NG; Tsai S; Christians KK; Clarke CN; Mogal H; White S; Rilling W; Gamblin TC
    HPB (Oxford); 2017 Aug; 19(8):659-666. PubMed ID: 28552299
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of hepatocellular carcinoma with portal vein thrombosis.
    Quirk M; Kim YH; Saab S; Lee EW
    World J Gastroenterol; 2015 Mar; 21(12):3462-71. PubMed ID: 25834310
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distinguishing Tumor From Bland Portal Vein Thrombus in Liver Transplant Candidates With Hepatocellular Carcinoma: the A-VENA Criteria.
    Sherman CB; Behr S; Dodge JL; Roberts JP; Yao FY; Mehta N
    Liver Transpl; 2019 Feb; 25(2):207-216. PubMed ID: 30246323
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatocellular carcinoma patients with portal vein thrombosis treated with robotic radiosurgery: Interim results of a prospective study.
    Dutta D; Tatineni T; Yarlagadda S; Gupte A; Reddy SK; Madhavan R; Nair H; Sasidharan A; Kannan R; Pottayil SG; Holla R; Sudhindran S
    Indian J Gastroenterol; 2021 Aug; 40(4):389-401. PubMed ID: 34694581
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patients with hepatocellular carcinoma and portal vein tumour thrombosis after successful downstaging may be candidates for liver transplantation: A meta-analysis.
    Liu J; Qian J; Yang Z; Zhou L; Zheng S
    J Hepatol; 2024 May; 80(5):e219-e221. PubMed ID: 37939856
    [No Abstract]   [Full Text] [Related]  

  • 18. Disseminated intravascular coagulation during liver transplantation unleashed by protamine.
    Raveh Y; Shatz V; Lindsay M; Nicolau-Raducu R
    J Clin Anesth; 2019 Nov; 57():117-118. PubMed ID: 30991212
    [No Abstract]   [Full Text] [Related]  

  • 19. Safety and efficacy of 90Y radiotherapy for hepatocellular carcinoma with and without portal vein thrombosis.
    Kulik LM; Carr BI; Mulcahy MF; Lewandowski RJ; Atassi B; Ryu RK; Sato KT; Benson A; Nemcek AA; Gates VL; Abecassis M; Omary RA; Salem R
    Hepatology; 2008 Jan; 47(1):71-81. PubMed ID: 18027884
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatocellular carcinoma invading portal venous system in cirrhosis: long-term results of percutaneous radiofrequency ablation of both the nodule and portal vein tumor thrombus. A case control study.
    Giorgio A; Calisti G; Montesarchio L; Scognamiglio U; Matteucci P; Coppola C; Scarano F; Amendola F; Giorgio V
    Anticancer Res; 2014 Nov; 34(11):6785-90. PubMed ID: 25368292
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.